Rebif Sales Data

Rank 50 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Rebif U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 50 (9) -6.27% -12.61%
Q3 2013 41 (3) -8.17% -14.07%
Q2 2013 38 (3) -1.96% -6.41%
Q1 2013 41 (3) 6.61% -8.17%
Q4 2012 38 (4) 1.13% -3.92%
Q3 2012 42 (7) 8.88% 11.36%
Q2 2012 49 (13) 9.73% 5.93%
Q1 2012 62 (1) -0.21% -9.09%
Q4 2011 61 (7) 0.43% -0.34%
Q3 2011 54 (5) 1.48% -1.49%
Q2 2011 59 (2) 0.25% -0.66%
Q1 2011 61

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
April 2, 2014Rare, But Serious, Side Effect Reported With One MS Drug

Learn how medication, diet, and exercise are key to managing Multiple Sclerosis. Click Here

Close
Hide
(web4)